UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models

PloS one, 2013-04, Vol.8 (4), p.e62183-e62183

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Universal and Platelet Reactivity Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome

The American journal of cardiology, 2013-08, Vol.112 (3), p.355-362

2013

Volltextzugriff (PDF)

Timing of recurrent venous thromboembolism early after the index event: A meta-analysis of randomized controlled trials

Thrombosis research, 2013-10, Vol.132 (4), p.420-426

2013

Volltextzugriff (PDF)

Effect of pharmacist intervention on glycemic control in diabetes

Diabetes research and clinical practice, 2011-05, Vol.92 (2), p.145-152

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Ranolazine Added to Standard-of-Care Treatment in Patients With Chronic Stable Angina Pectoris

The American journal of cardiology, 2014-04, Vol.113 (8), p.1306-1311

2014

Volltextzugriff (PDF)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States

Pediatric pulmonology, 2021-09, Vol.56 (9), p.2833-2844

2021

Volltextzugriff (PDF)

Universal versus platelet reactivity assay-driven use of P2Y12 inhibitors in acute coronary syndrome patients: cost-effectiveness analyses for six European perspectives

Thrombosis and haemostasis, 2014-01, Vol.111 (1), p.103-110

2014

Volltextzugriff (PDF)

The burden of cystic fibrosis in the Medicaid population

ClinicoEconomics and outcomes research, 2018-01, Vol.10, p.423-431

2018

Volltextzugriff (PDF)

Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients

Health and quality of life outcomes, 2013-06, Vol.11 (1), p.105-105, Article 105

2013

Volltextzugriff (PDF)

TCT-162 Universal Versus Platelet Reactivity Assay-Driven Use of P2Y12 Inhibitors in Acute Coronary Syndrome Patients: Cost-Effectiveness Analyses from Five European Perspectives

Journal of the American College of Cardiology, 2013-10, Vol.62 (18), p.B52-B52

2013

Volltextzugriff (PDF)

Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation

Journal of clinical epidemiology, 2014-10, Vol.67 (10), p.1093-1102

2014

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism

Thrombosis research, 2014-05, Vol.133 (5), p.743-749

2014

Volltextzugriff (PDF)

Impact of angina frequency on health utility values of patients with chronic stable angina

Health and quality of life outcomes, 2014-03, Vol.12 (1), p.39-39, Article 39

2014

Volltextzugriff (PDF)

Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.2085-2094

2017

Volltextzugriff (PDF)

CRT-32 Universal Ticagrelor Versus Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome Patients: A Cost-Effectiveness Analysis

JACC. Cardiovascular interventions, 2013-02, Vol.6 (2), p.S11-S11

2013

Volltextzugriff (PDF)

Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients

BMJ open, 2013-01, Vol.3 (5), p.e002798

2013

Volltextzugriff (PDF)

Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US

ClinicoEconomics and outcomes research, 2017-01, Vol.9, p.485-494

2017

Volltextzugriff (PDF)

Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort

Patient related outcome measures, 2016-01, Vol.7 (Issue 1), p.13-18

2016

Volltextzugriff (PDF)

2198. Healthcare Utilization During Acute Medically Attended Respiratory Syncytial Virus (RSV) Episodes among Infants in the United States

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

Abstract 200: Cost-Effectiveness of Newer Anticoagulants for Stroke Prevention in Atrial Fibrillation

Circulation Cardiovascular quality and outcomes, 2013-05, Vol.6 (suppl_1)

2013

Volltextzugriff (PDF)

Mapping of multiple sclerosis walking scale health outcomes: an independent validation in a randomized control cohort

Patient related outcome measures, 2016-01, Vol.7, p.13

2016

Volltextzugriff (PDF)

Mapping of multiple sclerosis walking scale

Patient related outcome measures, 2016-01, Vol.7, p.13

2016

Volltextzugriff (PDF)

Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models. e62183

PloS one, 2013-04, Vol.8 (4)

2013

Volltextzugriff (PDF)

Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States

Journal of managed care & specialty pharmacy, 2015-09, Vol.21 (9), p.824-833

2015

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models

Cost-Effectiveness of Universal and Platelet Reactivity Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome

Timing of recurrent venous thromboembolism early after the index event: A meta-analysis of randomized controlled trials

Effect of pharmacist intervention on glycemic control in diabetes

Cost-Effectiveness of Ranolazine Added to Standard-of-Care Treatment in Patients With Chronic Stable Angina Pectoris

Healthcare resource utilization and costs among children with cystic fibrosis in the United States

Universal versus platelet reactivity assay-driven use of P2Y12 inhibitors in acute coronary syndrome patients: cost-effectiveness analyses for six European perspectives

The burden of cystic fibrosis in the Medicaid population

Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients

TCT-162 Universal Versus Platelet Reactivity Assay-Driven Use of P2Y12 Inhibitors in Acute Coronary Syndrome Patients: Cost-Effectiveness Analyses from Five European Perspectives

Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation

Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism

Impact of angina frequency on health utility values of patients with chronic stable angina

Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations

CRT-32 Universal Ticagrelor Versus Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome Patients: A Cost-Effectiveness Analysis

Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients

Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US

Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort

2198. Healthcare Utilization During Acute Medically Attended Respiratory Syncytial Virus (RSV) Episodes among Infants in the United States

Abstract 200: Cost-Effectiveness of Newer Anticoagulants for Stroke Prevention in Atrial Fibrillation

Mapping of multiple sclerosis walking scale health outcomes: an independent validation in a randomized control cohort

Mapping of multiple sclerosis walking scale

Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models. e62183

Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States

Suchergebnisse filtern